Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Mesleh Shayeb A"'
Autor:
Mesleh Shayeb, Akram1 (AUTHOR) ameslehshayeb@health.ucsd.edu, Barnes, Richard F.W.1 (AUTHOR), Hanacek, Cris1 (AUTHOR), Aguero, Peter2 (AUTHOR), Steiner, Bruno3 (AUTHOR), Bailey, Cindy4 (AUTHOR), Quon, Doris4 (AUTHOR), Kruse‐Jarres, Rebecca3 (AUTHOR), von Drygalski, Annette1,5 (AUTHOR)
Publikováno v:
Haemophilia. Sep2021, Vol. 27 Issue 5, p866-875. 10p. 1 Chart, 3 Graphs.
Autor:
Cindy Bailey, Bruno Steiner, Akram Mesleh Shayeb, Richard F. W. Barnes, Peter Aguero, Doris Quon, Rebecca Kruse-Jarres, Annette von Drygalski, Cris Hanacek
Publikováno v:
Haemophilia. 27:866-875
Background Painful arthropathy is a long-term complication in patients with hemophilia (PWH), affecting mobility and quality of life. A major barrier for the appraisal of joint health is the absence of point-of-care (POC) imaging modalities to prompt
Publikováno v:
Journal of Pediatric Hematology/Oncology. 41:e72-e78
Recombinant activated factor VII (rFVIIa) has been used off-label to treat or prevent severe bleeding in patients for whom conventional treatments are unsuccessful. However, studies in children remain limited.To examine the efficacy and safety of rFV
Publikováno v:
Blood coagulationfibrinolysis : an international journal in haemostasis and thrombosis. 31(7)
Bleeding among critically ill paediatric haematology/oncology (CIPHO) patients leads to significant morbidity and mortality. Recombinant activated factor VII (rFVIIa) has shown some benefits in previous reported off-label use when conventional therap
Autor:
Bruno Steiner, Annette von Drygalski, Rebecca Kruse-Jarres, Andres Flores, Nicolas Gallastegui Crestani, Akram Mesleh Shayeb, Richard F. W. Barnes, Cris Hanacek, Cindy Bailey, Peter Aguero, Doris Quon
Publikováno v:
Blood. 136:20-21
Introduction: Clinical scoring systems, such as the Hemophilia Joint Health Score (HJHS), and imaging modalities (radiographs and magnetic resonance) are important instruments for the evaluation of hemophilic joint health. However, they are semi-quan
Publikováno v:
Annals of Oncology. 31:S292-S293
Autor:
Bradley Alexander McGregor, Hannah Dzimitrowicz, Rana R. McKay, Marina D. Kaymakcalan, Akram Mesleh Shayeb, Nazli Dizman, Tian Zhang, Toni K. Choueiri, Danielle Urman, Daniel Y.C. Heng, Sumanta K. Pal, Akhilesh Sivakumar, Xin Gao, Pedro C. Barata, Luis Meza, Mehmet Asim Bilen, Chun Loo Gan
Publikováno v:
Journal of Clinical Oncology. 39:291-291
291 Background: Venous thromboembolism (VTE) is the second leading cause of death in patients with cancer. Despite cabo improving RCC outcomes, VTE management in these patients remains a challenge, partly due to poor understanding of cabo safety prof
Publikováno v:
Journal of Clinical Oncology. 38:3632-3632
3632 Background: HER2 alterations is a predictive biomarker for anti-HER2 regimen. Success in breast and gastric cancers with anti-HER2 therapies translated to explore their efficacy in other tumors. Currently, measurement of HER2 can be done by asse
Autor:
Ashley Brown, Akram Mesleh Shayeb, Sue C. Kaste, Jeremie H. Estepp, Kerri Nottage, Matthew P. Smeltzer
Publikováno v:
Pediatric bloodcancer. 65(12)
Avascular necrosis (AVN) is a chronic bone complication of sickle cell disease (SCD) resulting in significant morbidity. Understanding associated risk factors can facilitate risk-based screening, earlier identification, and prompt intervention. Betwe
Autor:
Akram Mesleh Shayeb, Annette von Drygalski, Cindy Bailey, Bruno Steiner, Cris Hanacek, Rebecca Kruse-Jarres, Doris Quon, Andres Flores, Richard F. W. Barnes
Publikováno v:
Blood. 134:905-905
Introduction: Recurrent joint bleeding in patients with congenital hemophilia causes progressive arthropathy, characterized by reduced range of motion, synovial proliferation and osteochondral damage. Chronic hemophilic arthropathy remains a leading